Technology
Health
Biotechnology

SCYNEXIS

15,884

$0.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0185 (-2.39%) Today
+$0.0058 (+0.77%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SCYNEXIS and other stocks, options, ETFs, and crypto commission-free!

About SCYX

SCYNEXIS, Inc. Common Stock, also called SCYNEXIS, is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. Read More The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.

CEO
Marco Taglietti
Employees
27
Headquarters
Jersey City, New Jersey
Founded
1999
Market Cap
74.52M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
903.43K
High Today
$0.78
Low Today
$0.732
Open Price
$0.78
Volume
1.29M
52 Week High
$1.44
52 Week Low
$0.50

Collections

Technology
Health
Biotechnology
2014 IPO
US
North America

SCYX Earnings

-$0.46
-$0.30
-$0.15
$0.01
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 6, Pre-Market

You May Also Like

SQBG
ERF
CAKE
WRB-B
CTR
JP
BLES
IMAB
TMHC
PH
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy SCYX

Market Price$0.76
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell SCYNEXIS stock and options commission-free.
LearnBlogCareersHelpLog InSign Up